Success Metrics

Completion Rate
0%(0/2)
Active Trials
1(33%)
Terminated
2(67%)

Phase Distribution

Ph phase_4
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(2)

Detailed Status

Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 42 (66.7%)

Trials by Status

terminated267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_3

Topical Cryotherapy and Keloid/Hypertrophic Scars

NCT07336368
terminatedphase_4

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

NCT04582669
terminatedphase_4

Intralesional Steroids in the Treatment of Alopecia Areata

NCT01898806

Clinical Trials (3)

Showing 3 of 3 trials
NCT07336368Phase 3

Topical Cryotherapy and Keloid/Hypertrophic Scars

Recruiting
NCT04582669Phase 4

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

Terminated
NCT01898806Phase 4

Intralesional Steroids in the Treatment of Alopecia Areata

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3